Attenuating Effect of Ginkgo biloba Leaves Extract on Liver Fibrosis Induced by Thioacetamide in Mice

Table 2

Liver SOD, GSH, glycogen, total protein, and total lipid levels of control, TAA, TTA plus G. biloba leaves extract, and G. biloba leaves extract treated mice (𝑛 = 7). Percentage changes are included in parentheses.

Parameters	Treatments
	Control	TAA	TAA + leaves extract	Leaves extract
SOD (U/mg tissue)	5.26±0.67	3.47 ± 0.42^ab	4.23 ± 0.49^ac	5.34 ± 0.52
		(−34.0)	(−19.6)	(+1.5)
GSH (μmol/g tissue)	8.69±0.82	6.21 ± 0.55^ab	6.94 ± 0.62^ac	8.90 ± 0.68
		(−28.5)	(−20.1)	(+2.4)
Glycogen (mg/g tissue)	9.34±0.87	7.34 ± 1.19^ab	8.06 ± 0.81^a	9.03 ± 1.25
		(−21.4)	(−13.7)	(−3.3)
Total protein (mg/g tissue)	247.43±12.61	204.00 ± 8.43^ab	236.11 ± 17.58	254.29 ± 18.63
		(−17.6%)	(−4.6%)	(+2.8%)
Total lipid (mg/g tissue)	143.00±8.76	195.43 ± 14.97^ab	177.14 ± 8.09^ac	140.29 ± 10.26
		(+36.7)	(+23.9)	(−1.9)

^aIndicates a significant difference between control and treated groups.
^bIndicates a significant difference between the group treated with TAA and groups treated with TAA plus G. biloba leaves extract and G. biloba leaves extract.
^cIndicates a significant difference between the group treated with TAA plus G. biloba leaves extract and group treated with G. biloba leaves extract.